Share Name Share Symbol Market Type Share ISIN Share Description
Verona Pharma Plc LSE:VRP London Ordinary Share GB00BYW2KH80 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 48.00 5,000 08:00:00
Bid Price Offer Price High Price Low Price Open Price
46.00 50.00 48.00 48.00 48.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -24.13 -18.90 50
Last Trade Time Trade Type Trade Size Trade Price Currency
14:23:16 O 1,000 49.50 GBX

Verona Pharma (VRP) Latest News

More Verona Pharma News
Verona Pharma Takeover Rumours

Verona Pharma (VRP) Share Charts

1 Year Verona Pharma Chart

1 Year Verona Pharma Chart

1 Month Verona Pharma Chart

1 Month Verona Pharma Chart

Intraday Verona Pharma Chart

Intraday Verona Pharma Chart

Verona Pharma (VRP) Discussions and Chat

Verona Pharma Forums and Chat

Date Time Title Posts
14/10/201921:28Verona Pharma: Developing first in class drugs for respiratory diseases1,045
30/10/201808:41Still time to look at Verona Pharma (VRP)-
01/8/201810:42Verona Pharma (VRP) One to Watch -
16/2/201517:30Verona Pharma with Charts & News11,549
24/11/201112:54verona pharma173

Add a New Thread

Verona Pharma (VRP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Verona Pharma trades in real-time

Verona Pharma (VRP) Top Chat Posts

DateSubject
19/10/2019
09:20
Verona Pharma Daily Update: Verona Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker VRP. The last closing price for Verona Pharma was 48p.
Verona Pharma Plc has a 4 week average price of 45p and a 12 week average price of 40p.
The 1 year high share price is 125p while the 1 year low share price is currently 40p.
There are currently 105,075,513 shares in issue and the average daily traded volume is 26,039 shares. The market capitalisation of Verona Pharma Plc is £50,436,246.24.
30/7/2019
23:14
shakin not stirred: By the time we get the update someone might wish to ask what JAk thinks of the share price and if the drug is all he reckons as no sign of Significant shareholder value. If so then in which decade should we expect to see it. Why do they reward themselves disproportionately to the share price performance and is he aware no one is currently in profit yet he has continued to recruit at will and no further advancement to our lead drug if not only drug enisfenterine in my opinion. Does he see 40p as representing significant shareholder value. Please someone ask the question. Ask Jak at what share price level does this need to reach for them to call it a day and put shareholders out of their misery. All the above my opinion and can anyone post a Nasdaq share price and how that equates at the exchange rate to the share price on aim. Sorry for being slightly as have forgotten how many shares are worth the other as seems an age ago
15/7/2019
09:56
haff1: Ive been in VRP for nearly 10 years now!! Foolish I know but its always been jam tomorrow for 10 years with a stedily decreasing share price and value...Its so depressing its untrue. I really cant afford to come out now and have to just hope ....though I stopped holding my breadth about 6 years ago ..... no 8 years ago....that it will come to market and have been worthwhile! Trouble is will it come to market before I pass away?
09/1/2019
13:11
tomboyb: https://uk.advfn.com/stock-market/london/verona-pharma-VRP/share-news/Verona-Pharma-plc-Verona-Pharma-Receives-Who-Appro/79020332 I wonder if saffy is buying a few -
20/2/2018
19:43
combo83: The risk/reward here currently looks very favourable. Well funded, important newsflow within 1-2 months, consistent director buying, and different brokers with price targets at multiples of the current share price. GLA, could be a very interesting year. PS - timboo, perhaps time for an update of the header? :)
09/11/2017
12:04
haff1: Its a shame the share price doesnt reflect this..
23/6/2017
08:31
kwizza: Is this a new low for the share price
23/2/2017
11:22
shakin not stirred: I am waiting to see if Nasdaq listing makes a difference but need to get to £2 new money to break even. Will bale out when that is reached. Unless anything materially changes as to indicating a good news flow. At the moment it is a Jam tomorrow as have been the last few years for me and longer for others. None of us have invested in companys for F.A. but that is the current return at this moment in time. That is the current reality of the share price.
15/2/2017
08:49
timbo003: The recent share price movement is a bit disappointing, but similar to that of Motif Bio immediately before it had its Nasdaq listing. With US listings for UK listed AIM companies, be careful of what you wish for!
25/1/2017
16:50
meijiman: The share price has not been too clever of late.......
20/1/2017
22:53
shakin not stirred: The belief is that the minimum share price on the nasdaq is $2 so that will happen and in my mind we will be fully subscribed and job don e with enough money to take it to commercialisation and GSK or alternatively large paharma like Bayer to buy a huge lump of shares, followed by a partnership deal. 9p equivalent old money this year and 20p eventual. All very good news.
Verona Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
VRP
Verona Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 15:17:45